Richard C.A. Sainson

4.8k total citations
38 papers, 3.5k citations indexed

About

Richard C.A. Sainson is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Richard C.A. Sainson has authored 38 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 16 papers in Oncology and 8 papers in Immunology. Recurrent topics in Richard C.A. Sainson's work include Angiogenesis and VEGF in Cancer (13 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Developmental Biology and Gene Regulation (7 papers). Richard C.A. Sainson is often cited by papers focused on Angiogenesis and VEGF in Cancer (13 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Developmental Biology and Gene Regulation (7 papers). Richard C.A. Sainson collaborates with scholars based in United Kingdom, United States and France. Richard C.A. Sainson's co-authors include Christopher C.W. Hughes, Adrian L. Harris, Martin N. Nakatsu, James A. Harper, Jason Aoto, Jiliang Li, Helen Turley, Russell Leek, Sofía Pérez‐del‐Pulgar and Kevin Taylor and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Richard C.A. Sainson

38 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard C.A. Sainson United Kingdom 22 2.2k 714 695 473 454 38 3.5k
Patrizia Dell’Era Italy 31 2.7k 1.2× 574 0.8× 445 0.6× 329 0.7× 306 0.7× 69 4.1k
Amit Vasanji United States 37 1.9k 0.9× 836 1.2× 1.1k 1.6× 420 0.9× 349 0.8× 78 4.7k
Jörg W. Bartsch Germany 36 2.1k 1.0× 711 1.0× 1.1k 1.6× 576 1.2× 165 0.4× 111 4.1k
Thomas Korff Germany 35 2.5k 1.2× 577 0.8× 718 1.0× 515 1.1× 725 1.6× 75 4.8k
R. Grant Rowe United States 26 2.2k 1.0× 936 1.3× 908 1.3× 346 0.7× 314 0.7× 49 3.9k
Sandra A. Rempel United States 31 1.4k 0.6× 655 0.9× 796 1.1× 352 0.7× 225 0.5× 51 3.1k
Edith Bonnelye France 32 1.9k 0.9× 540 0.8× 1.2k 1.7× 306 0.6× 572 1.3× 58 3.8k
Barbara Garmy‐Susini France 28 1.8k 0.8× 653 0.9× 1.0k 1.5× 482 1.0× 173 0.4× 65 3.2k
Tracy‐Ann Read United States 21 1.7k 0.8× 469 0.7× 643 0.9× 286 0.6× 228 0.5× 39 2.8k
Christophe Deroanne Belgium 29 1.8k 0.8× 813 1.1× 557 0.8× 271 0.6× 198 0.4× 60 3.1k

Countries citing papers authored by Richard C.A. Sainson

Since Specialization
Citations

This map shows the geographic impact of Richard C.A. Sainson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard C.A. Sainson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard C.A. Sainson more than expected).

Fields of papers citing papers by Richard C.A. Sainson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard C.A. Sainson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard C.A. Sainson. The network helps show where Richard C.A. Sainson may publish in the future.

Co-authorship network of co-authors of Richard C.A. Sainson

This figure shows the co-authorship network connecting the top 25 collaborators of Richard C.A. Sainson. A scholar is included among the top collaborators of Richard C.A. Sainson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard C.A. Sainson. Richard C.A. Sainson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lu, Li‐Chun, Yi‐Hsuan Lee, L. Mitchell, et al.. (2022). ICOS-Positive Regulatory T Cells in Hepatocellular Carcinoma: The Perspective from Digital Pathology Analysis. Oncology. 100(8). 419–428. 2 indexed citations
3.
Patel, Manish R., Aung Naing, Howard A. Burris, et al.. (2021). A phase 1/2 open-label study of KY1044, an anti-ICOS antibody with dual mechanism of action, as single agent and in combination with atezolizumab, in adult patients with advanced malignancies.. Journal of Clinical Oncology. 39(15_suppl). 2624–2624. 14 indexed citations
4.
Sainson, Richard C.A., Matthew McCourt, Anil K. Thotakura, et al.. (2018). Abstract 2792: The combination of immune checkpoint blockers with the anti-ICOS KY1044 antibody results in a strong tumor response. Cancer Research. 78(13_Supplement). 2792–2792. 1 indexed citations
5.
Xie, Bangwen, Michal R. Tomaszewski, André Neves, et al.. (2017). Optoacoustic Detection of Early Therapy-Induced Tumor Cell Death Using a Targeted Imaging Agent. Clinical Cancer Research. 23(22). 6893–6903. 24 indexed citations
6.
Gavaghan, David J., James M. Osborne, Ian P. Barrett, et al.. (2017). A mathematical model of antibody-dependent cellular cytotoxicity (ADCC). Journal of Theoretical Biology. 436. 39–50. 19 indexed citations
7.
Ghadially, Hormas, Lee R. Brown, Chris J. Lloyd, et al.. (2017). MHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissue. British Journal of Cancer. 116(9). 1208–1217. 83 indexed citations
8.
Bazán‐Peregrino, Miriam, Richard C.A. Sainson, Robert Carlisle, et al.. (2013). Combining virotherapy and angiotherapy for the treatment of breast cancer. Cancer Gene Therapy. 20(8). 461–468. 23 indexed citations
9.
Li, Jiliang, Richard C.A. Sainson, Chern Ein Oon, et al.. (2011). DLL4-Notch Signaling Mediates Tumor Resistance to Anti-VEGF Therapy In Vivo. Cancer Research. 71(18). 6073–6083. 187 indexed citations
10.
Oon, Chern Ein, Richard C.A. Sainson, Helen Sheldon, et al.. (2010). 360 Role of DLL4 and JAG1 in tumour angiogenesis. European Journal of Cancer Supplements. 8(5). 92–92. 1 indexed citations
11.
Turley, Helen, Graham Steers, Richard C.A. Sainson, et al.. (2009). Nuclear and membrane expression of the angiogenesis regulator Delta Like Ligand 4(DLL4) in normal and malignant human tissues (Histopathology (2009) 54 (598-606)). Histopathology. 55. 463–464. 1 indexed citations
12.
Bazán‐Peregrino, Miriam, Richard C.A. Sainson, Robert Carlisle, et al.. (2008). Virotherapy expressing regulatory angiogenic gene therapy in treatment of breast cancer. Human Gene Therapy. 19. 415–415. 1 indexed citations
13.
Sainson, Richard C.A. & Adrian L. Harris. (2008). Regulation of angiogenesis by homotypic and heterotypic notch signalling in endothelial cells and pericytes: from basic research to potential therapies. Angiogenesis. 11(1). 41–51. 72 indexed citations
14.
Williams, Cassin Kimmel, Marta Segarra, Maria De La Luz Sierra, et al.. (2008). Regulation of CXCR4 by the Notch Ligand Delta-like 4 in Endothelial Cells. Cancer Research. 68(6). 1889–1895. 48 indexed citations
15.
Li, Jiliang, Richard C.A. Sainson, Wen Shi, et al.. (2007). Delta-like 4 Notch Ligand Regulates Tumor Angiogenesis, Improves Tumor Vascular Function, and Promotes Tumor Growth In vivo. Cancer Research. 67(23). 11244–11253. 242 indexed citations
16.
Pedram, Ali, Mahnaz Razandi, Richard C.A. Sainson, et al.. (2007). A Conserved Mechanism for Steroid Receptor Translocation to the Plasma Membrane. Journal of Biological Chemistry. 282(31). 22278–22288. 368 indexed citations
17.
Harrington, Laura, Richard C.A. Sainson, Cassin Kimmel Williams, et al.. (2007). Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells. Microvascular Research. 75(2). 144–154. 172 indexed citations
18.
Sainson, Richard C.A. & Adrian L. Harris. (2007). Anti-Dll4 therapy: can we block tumour growth by increasing angiogenesis?. Trends in Molecular Medicine. 13(9). 389–395. 58 indexed citations
19.
Nakatsu, Martin N., Richard C.A. Sainson, Jason Aoto, et al.. (2003). Angiogenic sprouting and capillary lumen formation modeled by human umbilical vein endothelial cells (HUVEC) in fibrin gels: the role of fibroblasts and Angiopoietin-1☆. Microvascular Research. 66(2). 102–112. 374 indexed citations
20.
Nakatsu, Martin N., Richard C.A. Sainson, Sofía Pérez‐del‐Pulgar, et al.. (2003). VEGF121 and VEGF165 Regulate Blood Vessel Diameter Through Vascular Endothelial Growth Factor Receptor 2 in an in vitro Angiogenesis Model. Laboratory Investigation. 83(12). 1873–1885. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrizia Dell’Era Breakdown of academic impact, for papers by Amit Vasanji Breakdown of academic impact, for papers by Jörg W. Bartsch Breakdown of academic impact, for papers by Thomas Korff Breakdown of academic impact, for papers by R. Grant Rowe Breakdown of academic impact, for papers by Sandra A. Rempel Breakdown of academic impact, for papers by Edith Bonnelye Breakdown of academic impact, for papers by Barbara Garmy‐Susini Breakdown of academic impact, for papers by Tracy‐Ann Read Breakdown of academic impact, for papers by Christophe Deroanne
Rankless by CCL
2026